COVID-19 Q&A: Part 1
COVID-19: Answering the Questions, Part 1

Released: June 05, 2020

Expiration: June 04, 2021

Vikramjit Mukherjee
Vikramjit Mukherjee, MD

Activity

Progress
1
Course Completed

In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management. 

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources